The North America Sciatica Treatment Market should witness market growth of 2.4% CAGR during the forecast period (2022-2028).
Sciatica pain radiates from the lumbar region of the body (lower back) to the back of the thigh. However, it might extend below the knee as well. The biggest nerve in the human body is the sciatic nerve. The sciatic nerve originates from the lumbar spinal cords nerve roots in the lower back region and extends across the buttock region, directing nerve terminals to the lower limb. A lumbar disc herniation is a common cause of sciatica because it presses directly on the nerve. Sciatica symptoms may be brought on by any factor that inflames or irritates the sciatic nerve.
Radiculopathy is a word used to describe abnormalities in the intervertebral disc caused by nerve irritation. Other causes of sciatica pain, besides a stretched nerve from a disc, include injury, internal bleeding, infections in or around the lumbar spine, muscle, tumors, and nerve irritation from nearby bone. The inflammation of the sciatic nerve may sometimes produce sciatica pain during pregnancy. Several risk factors accompany the discomfort in the sciatic nerve. They include lumbar spine trauma, slipped discs, lumbar disc disease, and degenerative arthritis.
The number of Americans 65 and over increased from 40.3 million in the 2010 Census to 54.1 million in the population estimates as of July 1, 2019, according to the US Census Bureau. Those who are older are more susceptible to illnesses like sciatica. The North American region is anticipated to occupy a significant share of the sciatica market over the forecast period. The United States is one of the most affected countries in the world due to the relatively high numbers of patients struggling with sciatica and higher in the North American geographical area as the patient population is rising compared to other countries.
The US market dominated the North America Sciatica Treatment Market by Country in 2021 and would continue to be a dominant market till 2028; thereby, achieving a market value of $215,115.4 Thousands by 2028. The Canada market is poised to grow at a CAGR of 4.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 3.8% during (2022-2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
Sciatica pain radiates from the lumbar region of the body (lower back) to the back of the thigh. However, it might extend below the knee as well. The biggest nerve in the human body is the sciatic nerve. The sciatic nerve originates from the lumbar spinal cords nerve roots in the lower back region and extends across the buttock region, directing nerve terminals to the lower limb. A lumbar disc herniation is a common cause of sciatica because it presses directly on the nerve. Sciatica symptoms may be brought on by any factor that inflames or irritates the sciatic nerve.
Radiculopathy is a word used to describe abnormalities in the intervertebral disc caused by nerve irritation. Other causes of sciatica pain, besides a stretched nerve from a disc, include injury, internal bleeding, infections in or around the lumbar spine, muscle, tumors, and nerve irritation from nearby bone. The inflammation of the sciatic nerve may sometimes produce sciatica pain during pregnancy. Several risk factors accompany the discomfort in the sciatic nerve. They include lumbar spine trauma, slipped discs, lumbar disc disease, and degenerative arthritis.
The number of Americans 65 and over increased from 40.3 million in the 2010 Census to 54.1 million in the population estimates as of July 1, 2019, according to the US Census Bureau. Those who are older are more susceptible to illnesses like sciatica. The North American region is anticipated to occupy a significant share of the sciatica market over the forecast period. The United States is one of the most affected countries in the world due to the relatively high numbers of patients struggling with sciatica and higher in the North American geographical area as the patient population is rising compared to other countries.
The US market dominated the North America Sciatica Treatment Market by Country in 2021 and would continue to be a dominant market till 2028; thereby, achieving a market value of $215,115.4 Thousands by 2028. The Canada market is poised to grow at a CAGR of 4.8% during (2022-2028). Additionally, The Mexico market should witness a CAGR of 3.8% during (2022-2028).
Based on Type, the market is segmented into Chronic, Acute and Others. Based on Distribution Channel, the market is segmented into Retail & Specialty Pharmacies, Hospital Pharmacies and Online Providers. Based on Drug Class, the market is segmented into non-Steroidal anti-inflammatory, Steroids, Antidepressants and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sorrento Therapeutics, Inc., Alkem Laboratories Ltd., Amneal Pharmaceuticals, Inc., Aurobindo Pharma Limited, Novartis AG, and Cadila Healthcare Ltd. (Zydus Cadila)
Scope of the Study
By Type
- Chronic
- Acute
- Others
By Distribution Channel
- Retail & Specialty Pharmacies
- Hospital Pharmacies
- Online Providers
By Drug Class
- Non-Steroidal anti-inflammatory
- Steroids
- Antidepressants
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sorrento Therapeutics, Inc.
- Alkem Laboratories Ltd.
- Amneal Pharmaceuticals, Inc.
- Aurobindo Pharma Limited
- Novartis AG
- Cadila Healthcare Ltd. (Zydus Cadila)
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Sciatica Treatment Market, by Type
1.4.2 North America Sciatica Treatment Market, by Distribution Channel
1.4.3 North America Sciatica Treatment Market, by Drug Class
1.4.4 North America Sciatica Treatment Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Sciatica Treatment Market by Type
3.1 North America Chronic Market by Country
3.2 North America Acute Market by Country
3.3 North America Others Market by Country
Chapter 4. North America Sciatica Treatment Market by Distribution Channel
4.1 North America Retail & Specialty Pharmacies Market by Country
4.2 North America Hospital Pharmacies Market by Country
4.3 North America Online Providers Market by Country
Chapter 5. North America Sciatica Treatment Market by Drug Class
5.1 North America Non-Steroidal anti-inflammatory Market by Country
5.2 North America Steroids Market by Country
5.3 North America Antidepressants Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Sciatica Treatment Market by Country
6.1 US Sciatica Treatment Market
6.1.1 US Sciatica Treatment Market by Type
6.1.2 US Sciatica Treatment Market by Distribution Channel
6.1.3 US Sciatica Treatment Market by Drug Class
6.2 Canada Sciatica Treatment Market
6.2.1 Canada Sciatica Treatment Market by Type
6.2.2 Canada Sciatica Treatment Market by Distribution Channel
6.2.3 Canada Sciatica Treatment Market by Drug Class
6.3 Mexico Sciatica Treatment Market
6.3.1 Mexico Sciatica Treatment Market by Type
6.3.2 Mexico Sciatica Treatment Market by Distribution Channel
6.3.3 Mexico Sciatica Treatment Market by Drug Class
6.4 Rest of North America Sciatica Treatment Market
6.4.1 Rest of North America Sciatica Treatment Market by Type
6.4.2 Rest of North America Sciatica Treatment Market by Distribution Channel
6.4.3 Rest of North America Sciatica Treatment Market by Drug Class
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Johnson & Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental &Regional Analysis
7.2.4 Research & Development Expenses
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.4 Sun Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional & Segmental Analysis
7.4.4 Research & Development Expenses
7.5 Sorrento Therapeutics, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental Analysis
7.5.4 Research & Development Expenses
7.6 Alkem Laboratories Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Amneal Pharmaceuticals, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental
7.7.4 Research & Development Expenses
7.8 Aurobindo Pharma Limited
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Novartis AG
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.10. Cadila Healthcare Ltd. (Zydus Cadila)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
Companies Mentioned
- Abbott Laboratories
- Johnson & Johnson
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sorrento Therapeutics, Inc.
- Alkem Laboratories Ltd.
- Amneal Pharmaceuticals, Inc.
- Aurobindo Pharma Limited
- Novartis AG
- Cadila Healthcare Ltd. (Zydus Cadila)
Methodology
LOADING...
